(Press-News.org) EMBARGOED UNTIL: 2:39 P.M. PT, May 19, 2024
Session: A93 - CRITICAL CARE AND ACUTE CARE MEDICINE: DISPARITIES, QUALITY IMPROVEMENT, AND OUTCOMES
Examining the Association Between Hospital Environments and Intersectional Disparities in Mechanical Ventilation Outcomes
Date and Time: Sunday May 19, 2024, 2:39 p.m. PT
Location: San Diego Convention Center, Room 7A-B (Upper Level)
ATS 2024, San Diego – The odds of death for patients receiving mechanical ventilation for pneumonia or sepsis increase along with the diversity of hospitals’ patient populations, suggesting more systemic factors such as lack of resources and income levels may be to blame, according to research published at the ATS 2024 International Conference.
The study’s results are in line with the findings of previous studies that looked at the association between hospital racial diversity and mortality after heart attack, and rates of improvement in ICU mortality, according to the authors.
“Taken together, this data highlights the importance of a careful examination of factors that could be contributing to these adverse outcomes and suggests a need for adjusting resource allocation both to reduce inequity and improve patient outcomes,” said corresponding author Gwenyth Day, MD, third-year fellow, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus.
Health disparities research has focused mostly on the role of singular patient-level factors, such as race or income. Less attention has been paid to the hospital systems in which patients experience disparities. Dr. Day and colleagues previously showed that, for patients receiving mechanical ventilation for pneumonia or sepsis, Black women have highest risk-adjusted death rates while white men have the lowest risk-adjusted mortality rates.
To address this issue on a systemic basis, the team designed a study that would investigate disparities at the hospital level. They first identified non-surgical patients with pneumonia or sepsis treated with mechanical ventilation from seven geographically and racially diverse Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases from 2018 to 2019, across 1,045 hospitals and 16,405,853 hospitalizations.
After excluding hospitals with fewer than 25 patients of color with pneumonia/sepsis, the researchers categorized hospitals into quartiles of racial diversity by percentage of patients of color. They identified 161,560 eligible patients who received mechanical ventilation, of whom 13,786 were Black women and 58,828 were white men. The team evaluated the risk-adjusted odds of death for Black women compared to white men in all hospitals; Black women compared to white men by quartile of hospital diversity, and all patients based on quartile of hospital diversity.
Patients identified as Black women had a 37.6 percent mortality rate, while mortality rates for white men were 36 percent. Adjusted odds of death for patients identified as Black women versus white men did not significantly vary between quartiles of hospital racial diversity. All patients admitted to hospitals with greater racial diversity had higher risk-adjusted hospital mortality.
“Our findings suggest that hospitals with more racial diversity experience strain that affects all patients,” said Dr. Day. “This strain may be the result of other factors such as hospital resources, staffing, the types of hospital insurance payments, or neighborhood income.”
Future studies by the group will seek to understand the large degree of intersectional variability in mechanical ventilation mortality. They will identify hospitals with high and low variability in mechanical ventilation mortality based on race and gender and use qualitative and survey methodologies to better understand this variability. In the future, they hope to conduct a mixed survey-qualitative study to evaluate patient and provider experiences of bias, discrimination and practice variability at high and low variability hospitals to further dissect the observed differences in outcomes.
###
VIEW ABSTRACT
CONTACTS FOR MEDIA:
Dacia Morris, Director, Communications & Marketing, American Thoracic Society
dmorris@thoracic.org
Julia Milzer, Director of Media Relations, CU Anschutz
julia.milzer@cuanschutz.edu
END
Hospitals caring for diverse patient populations have higher mechanical ventilation mortality
2024-05-20
ELSE PRESS RELEASES FROM THIS DATE:
Spirometry clinical trial eligibility may differ with race-neutral equations
2024-05-19
EMBARGOED UNTIL: 9:15 a.m. PT, May 19, 2024
Session: A27 – Emerging Treatments and Therapeutic Strategies in COP: Results of Clinical Trials and Observational Studies
Impact of Race-Neutral Spirometry Reference Equations on Eligibility for Chronic Obstructive Pulmonary Disease Clinical Trials
Date and Time: Sunday, May 19, 9:15 a.m. PT
Location: San Diego Convention Center, Room 33A-C (Upper Level)
ATS 2024, San Diego – Equations that don’t use racially and ethnically adjusted spirometry results to help determine eligibility for chronic obstructive pulmonary disease (COPD) ...
World-first trial shows benefits of finding, treating undiagnosed asthma and COPD
2024-05-19
Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.
"It's estimated that 70 per cent of people with asthma or COPD go undiagnosed." said study lead Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital and professor at the University of ...
Acetaminophen shows promise in warding off acute respiratory distress syndrome, organ injury in patients with sepsis
2024-05-19
A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients’ risk of having organ injury or developing acute respiratory distress syndrome, a serious condition that allows fluid to leak into the lungs. Sepsis is the body’s uncontrolled and extreme response to an infection. While the trial did not improve mortality rates in all patients with sepsis regardless of severity, the researchers found that acetaminophen gave the greatest benefit to the patients most at risk for organ damage. With the therapy, those patients needed less assisted ...
Bisoprolol in patients with COPD at high risk of exacerbation
2024-05-19
About The Study: Among people with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation, treatment with the β1-selective β-blocker bisoprolol did not reduce the number of self-reported COPD exacerbations requiring treatment with oral corticosteroids, antibiotics, or both.
Quote from corresponding author Graham Devereux, M.D.:
“People with COPD are at increased risk of cardiovascular conditions that benefit from treatment with beta-blockers. However, there is a well-documented ...
Pamrevlumab for idiopathic pulmonary fibrosis
2024-05-19
About The Study: Among patients with idiopathic pulmonary fibrosis treated with pamrevlumab (a fully human monoclonal antibody that binds to and inhibits connective tissue growth factor activity) or placebo, there was no statistically significant between-group difference for the primary outcome of absolute change in forced vital capacity from baseline to week 48.
Quote from corresponding author, Ganesh Raghu, M.D.:
“Current treatment with the two drugs approved by regulatory agencies ...
Acetaminophen for prevention and treatment of organ dysfunction in critically ill patients with sepsis
2024-05-19
About The Study: In critically ill sepsis patients, treatment with intravenous acetaminophen for 5 days was safe but did not improve the primary end point of days alive and free of any organ support (dialysis, assisted ventilation, and vasopressors) to day 28 compared with placebo.
Corresponding Author: To contact the corresponding author, Lorraine B. Ware, M.D., email Lorraine.ware@vumc.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.8772)
Editor’s Note: Please see the ...
Measuring lung function more accurately and more equitably
2024-05-19
Removing race from equations that estimate lung function will shift the categorization of disease severity across patient populations, moving more Black individuals into an advanced disease category, according to new research led by scientists at Harvard Medical School. At the same time, more white and Hispanic people would be reclassified as having less advanced illness.
The findings, the research team said, suggest that adjusting lung function tests to include race — as has been the case historically — likely normalized worse lung function and downplayed disease severity among Black people.
The work, to be published May 19 in the New England Journal ...
Study reports ‘excellent’ outcomes for patients receiving optimized treatment for atrial fibrillation
2024-05-18
Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone. In a new study published in Heart Rhythm, researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation. One year after the procedure, 81.6 percent ...
Modular Communicative Leadless ICD is safe and exceeds performance expectations
2024-05-18
Wireless implantable cardioverter-defibrillators (ICDs) eliminate the lead-related complications that come with a wired ICD, but they are unsuitable for patients with ventricular tachycardia, when the heart beats too quickly, or bradycardia, when the resting heart rate is seen as low. Research led by Amsterdam UMC, that is published today in the New England Journal of Medicine, shows that the first wireless modular system suitable for these patient groups is safe and exceeds performance expectations. Opening the door for a wider ...
Patients seen by female gastroenterologists have significantly less health care utilization than patients seen by male providers
2024-05-18
WASHINGTON, DC (May 18, 2024) — Patients seen by a female gastroenterologist for an initial consultation are less likely to use medical care in the emergency department, hospital or primary care office for two years after their visit when compared to patients initially seen by male gastroenterologists, according to a study to be presented at Digestive Disease Week® (DDW) 2024.
“If there really is something different about the way female and male gastroenterologists provide care that impacts patient outcomes, it will be important to share these learnings broadly among health care providers ...